Analysed CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) News Sources
Cardio Diagnostics Holdings (CDIO) Aligns With Growing Shift Toward Predictive, Precision Medicine
18-06-2026
yahoo.com
Cardio Diagnostics Holdings (CDIO) Targets a $393B Heart Disease Problem With Epigenetics and AI
23-06-2026
yahoo.com
Atlas Healthcare Physicians to Cover Cardio Diagnostics’ Precision Cardiovascular Medicine Tests Across Its Network
24-06-2026
yahoo.com
Cardio Diagnostics Holdings (CDIO) Expands Coverage of Precision Cardiovascular Tests Through Atlas Healthcare Physicians
25-06-2026
yahoo.com
Cardio Diagnostics Holdings (CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease Detection
29-06-2026
yahoo.com
Cardio Diagnostics Holdings (CDIO) Leverages Epigenetics to Reveal Hidden Heart Disease Risks
30-06-2026
yahoo.com
Cardio Diagnostics Holdings (CDIO) Showcases Precision Cardiovascular Solutions for Employers, Health Plans
01-07-2026
yahoo.com
Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, August 20, 2026
05-08-2026
yahoo.com
Cardio Diagnostics Begins In-House Test Processing at Its New High Complexity CLIA-Certified Laboratory in Iowa City
18-08-2026
yahoo.com
What is the current price of CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ)?
The current price of CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) is $0.0168.
CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) absolute price change since previous trading day?
The absolute price change of CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) since the previous trading day is $-0.000699.
CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) percentage price change since previous trading day?
The percentage price change of CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) since the previous trading day is -3.9945%.
What is the most recent average sentiment score for CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ)?
The most recent average sentiment score for CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ)?
The most recent sentiment for CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ) is .
SEC-8K** Filing Available For CARDIO DIAGNOSTICS-CW26 (CDIOW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.